Phenominer Database Results (10 results)

 

How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Formula Value Units SEM SD Method Method Duration Post Insult Time Value Record ID Study ID
SS/NEisSlc both kidneys wet weight to body weight ratio controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 77 days) then tolvaptan (0.05 %) (for 49 days) Ishikawa M, et al., Int Heart J. 2013;54(2):98-106. kidney mass male 126 days 8 4.55 g/kg 0.06 0.17 post excision weight measurement 0.0 0 102324 2684
SS/NEisSlc systolic blood pressure controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 77 days) then tolvaptan (0.05 %) (for 49 days) Ishikawa M, et al., Int Heart J. 2013;54(2):98-106. arterial blood pressure trait male 126 days 8 undefined 235.0 mmHg 13.0 36.77 tail cuff plethysmography 0.0 0 102315 2684
SS/NEisSlc heart left ventricle end-diastolic diameter controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 77 days) then tolvaptan (0.05 %) (for 49 days) Ishikawa M, et al., Int Heart J. 2013;54(2):98-106. heart left ventricle end-diastolic diameter male 126 days 8 7.0 mm 0.2 0.57 transthoracic echocardiography 0.0 0 102321 2684
SS/NEisSlc serum urea nitrogen level controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 77 days) then tolvaptan (0.05 %) (for 49 days) Ishikawa M, et al., Int Heart J. 2013;54(2):98-106. blood urea nitrogen amount male 126 days 8 18.3 mg/dl 1.2 3.39 serum urea nitrogen analysis 0.0 0 102330 2684
SS/NEisSlc timed urine volume controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 77 days) then tolvaptan (0.05 %) (for 49 days) Ishikawa M, et al., Int Heart J. 2013;54(2):98-106. urine output male 126 days 8 83.3 ml/d 7.9 22.34 urine volume measurement method 0.0 0 102336 2684
SS/NEisSlc urine total protein excretion rate controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 77 days) then tolvaptan (0.05 %) (for 49 days) Ishikawa M, et al., Int Heart J. 2013;54(2):98-106. total urine protein amount male 126 days 8 124.0 mg/d 21.0 59.4 urine protein analysis 0.0 0 102339 2684
SS/NEisSlc body weight controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 77 days) then tolvaptan (0.05 %) (for 49 days) Ishikawa M, et al., Int Heart J. 2013;54(2):98-106. body mass male 126 days 8 386.0 g 6.0 16.97 body weighing method 0.0 0 102312 2684
SS/NEisSlc heart left ventricle fractional shortening controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 77 days) then tolvaptan (0.05 %) (for 49 days) Ishikawa M, et al., Int Heart J. 2013;54(2):98-106. heart left ventricle end-diastolic diameter male 126 days 8 44.3 % 1.0 2.83 transthoracic echocardiography 0.0 0 102318 2684
SS/NEisSlc serum creatinine level controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 77 days) then tolvaptan (0.05 %) (for 49 days) Ishikawa M, et al., Int Heart J. 2013;54(2):98-106. blood creatinine amount male 126 days 8 0.35 mg/dl 0.01 0.03 serum creatinine analysis 0.0 0 102327 2684
SS/NEisSlc creatinine clearance controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 77 days) then tolvaptan (0.05 %) (for 49 days) Ishikawa M, et al., Int Heart J. 2013;54(2):98-106. glomerular filtration trait male 126 days 8 3.6 ml/min 0.7 1.98 serum creatinine analysis 0.0 0 102333 2684